Alcon (ALC) R&D In Process (2022)
Alcon's quarterly R&D In Process came in at $175.0 million in Q4 2022, up 1650.0% quarter-over-quarter from $10.0 million in Q1 2022.
Alcon has reported R&D In Process for 1 years, with the latest figure at $175.0 million in Q4 2022.
- For the quarter ending Q4 2022, R&D In Process changed N/A year-over-year to $175.0 million; the trailing twelve-month figure through Dec 2022 stood at $175.0 million (changed N/A YoY), and the FY2022 full-year result was $175.0 million, changed N/A from the prior year.
- R&D In Process for Q4 2022 stood at $175.0 million, up from $10.0 million in the prior quarter.
- The five-year high for R&D In Process was $175.0 million in Q4 2022, with the low at $10.0 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D In Process (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Alcon | 26,430.30 | -1.58 Bn | 1.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 175.00 Mn |
| Mar 31, 2022 | 10.00 Mn |